Cited by 183Virology and Viral DiseasesVaccine Coverage and HesitancyPharmacovigilance and Adverse Drug Reactions

Neurologic disorders after measles-mumps-rubella vaccination

Mäkelä, Annamari, Nuorti, J. Pekka, Peltola, Heikki·2002·PEDIATRICS

Abstract

OBJECTIVE: The possibility of adverse neurologic events has fueled much concern about the safety of measles-mumps-rubella (MMR) vaccinations. The available evidence concerning several of the postulated complications is controversial. The aim of this study was to assess whether an association prevails between MMR vaccination and encephalitis, aseptic meningitis, and autism. METHODS: A retrospective study based on linkage of individual MMR vaccination data with a hospital discharge register was conducted among 535 544 1- to 7-year-old children who were vaccinated between November 1982 and June 1986 in Finland. For encephalitis and aseptic meningitis, the numbers of events observed within a 3-month risk interval after vaccination were compared with the expected numbers estimated on the basis of occurrence of encephalitis and aseptic meningitis during the subsequent 3-month intervals. Changes in the overall number of hospitalizations for autism after vaccination throughout the study period were searched for. In addition, hospitalizations because of inflammatory bowel diseases were checked for the children with autism. RESULTS: Of the 535 544 children who were vaccinated, 199 were hospitalized for encephalitis, 161 for aseptic meningitis, and 352 for autistic disorders. In 9 children with encephalitis and 10 with meningitis, the disease developed within 3 months of vaccination, revealing no increased occurrence within this designated risk period. We detected no clustering of hospitalizations for autism after vaccination. None of the autistic children made hospital visits for inflammatory bowel diseases. CONCLUSIONS: We did not identify any association between MMR vaccination and encephalitis, aseptic meningitis, or autism.

Integrity signals

Registry

Crossref · 10.1542/peds.110.5.957

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the Makela 2002 study, there was no significant increase in aseptic meningitis during the three months following MMR immunisation (P = 0.57).

    “No significant increase in aseptic meningitis was observed during the three months following immunisation (P = 0.57).”

    From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Makela 2002

  • In Makela 2002, out of 199 hospitalisations for encephalitis or encephalopathy, nine occurred within three months after MMR vaccination and 110 occurred more than three months after.

    “Out of the 199 hospitalisations for encephalitis or encephalopathy, nine occurred within three months after MMR vaccination, 110 occurred more than three months”

    From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Makela 2002

  • The study by Makela 2002 was weakened by the loss of 14% of the original birth cohorts and the effects of the rather long-term follow-up.

    “The study by Makela 2002 was weakened by the loss of 14% of the original birth cohorts and the effects of the rather longterm follow-up.”

    From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Makela 2002

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mäkelä, A., Nuorti, J. P., & Peltola, H.
Affiliations
  • Hospital for Children and Adolescents, Helsinki University Central Hospital, Helsinki, Finland
  • Department of Infectious Disease Epidemiology, National Public Health Institute, Helsinki, Finland
  • Helsinki University Hospital (FI)
Venue
PEDIATRICS
Published
2002-11-01
Volume
110
Issue
5
Pages
957-963
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
OpenAlex
W2122056698
Cited by
183
References
37
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 18 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 10 · 2014: 3 · 2013: 11 · 2012: 8
FWCI
11.66
Type
journal article
Language
en
Open access
closed
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
MMR vaccine, vaccine safety, encephalitis, aseptic meningitis, autism spectrum disorder, inflammatory bowel disease, childhood immunization, hospitalization
MeSH terms
Autistic Disorder, Child, Child, Hospitalized, Child, Preschool, Encephalitis, Finland, Humans, Infant, Meningitis, Aseptic, National Health Programs, Registries, Retrospective Studies, Measles-Mumps-Rubella Vaccine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review